News | April 08, 2022
Cadila Pharma launches world’s first three-dose rabies vaccine
The recombinant nanoparticle-based rabies G protein vaccine is prepared using virus-like particle technology.
The recombinant nanoparticle-based rabies G protein vaccine is prepared using virus-like particle technology.
The Blockchain-based solution was awarded the 2021 Bionow Technical Service Award
R&D investment up 11.7% to 4.1 billion EUR in 2021 (20.0% of net sales)
The company inaugurated the new production line at the Bengaluru facility to manufacture Computed Tomography Scanners
CanSinoBIO will continue to focus on developing a variety of innovative preventive vaccines in its diversified product pipeline with proprietary technologies, including the inhaled version of its COVID-19 vaccine, Convidecia
Supply increase to help meet growing global demand
The investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines
WHO’s post EUA inspection found deficiencies in Good Manufacturing Practice at the facility
It is one of the 15 medical device manufacturers approved under the government’s PLI scheme
The plant is scheduled to come on stream in September 2024
Subscribe To Our Newsletter & Stay Updated
